Myomo, Inc. (MYO)
Market Cap | 80.97M |
Revenue (ttm) | 19.55M |
Net Income (ttm) | -9.34M |
Shares Out | 28.81M |
EPS (ttm) | -0.27 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 336,052 |
Open | 3.070 |
Previous Close | 3.080 |
Day's Range | 2.810 - 3.080 |
52-Week Range | 0.497 - 5.580 |
Beta | 1.45 |
Analysts | Strong Buy |
Price Target | 6.50 (+131.32%) |
Earnings Date | Aug 7, 2024 |
About MYO
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of... [Read more]
Financial Performance
In 2023, Myomo's revenue was $19.24 million, an increase of 23.70% compared to the previous year's $15.56 million. Losses were -$8.15 million, -24.00% less than in 2022.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for MYO stock is "Strong Buy" and the 12-month stock price forecast is $6.5.
News
![](https://cdn.snapi.dev/images/v1/b/e/conf11-2465004.jpg)
Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/y/6/press19-2421684.jpg)
Myomo Reports First Quarter 2024 Financial Results
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/i/9/press15-2411905.jpg)
Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/f/e/conf18-2404602.jpg)
Myomo to Report First Quarter Financial Results on May 8, 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/a/6/press11-2347194.jpg)
Myomo Appoints Heather Getz to its Board of Directors
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/g/h/press14-2314214.jpg)
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/v/c/press20-2303440.jpg)
CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro®
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/8/j/conf4-2302308.jpg)
Myomo to Report Fourth Quarter Financial Results on March 7, 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/3/m/press12-2236930.jpg)
Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/j/h/press2-2232359.jpg)
Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/f/3/press10-2232365.jpg)
Myomo Reports Preliminary Fourth Quarter Revenue and Backlog
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/k/l/press14-2145233.jpg)
Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/q/o/press10-2141432.jpg)
CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/s/w/press6-2136448.jpg)
Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/8/k/conf5-2131535.jpg)
Myomo to Report Third Quarter Financial Results on November 7, 2023
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/h/1/press10-2042028.jpg)
Myomo Announces Closing of $4.4 Million Public Offering
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/n/y/press12-2037392.jpg)
Myomo Announces Pricing of $4.4 Million Public Offering
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/p/a/press15-2036829.jpg)
Myomo, Inc. Announces Proposed Public Offering
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/s/d/press19-2036802.jpg)
Myomo Receives Medicare Part B Reimbursement for First MyoPro® Claims
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/k/o/press19-2031351.jpg)
Myomo Announces Two German Social Court Rulings Ordering MyoPro® Reimbursement
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/1/o/press6-2015602.jpg)
Myomo Reports Second Quarter 2023 Financial Results Featuring Year Over Year Growth in Revenue and Operating Metrics
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/r/w/conf8-2002598.jpg)
Myomo to Report Second Quarter Financial Results on August 9, 2023
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/d/g/press14-1956919.jpg)
Centers for Medicare and Medicaid Services Accepts Myomo's Application to Classify the MyoPro® as a Brace
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/x/u/press13-1934536.jpg)
Myomo To Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
![](https://cdn.snapi.dev/images/v1/k/z/press6-1883444.jpg)
Myomo Reports First Quarter 2023 Financial Results Featuring 20% Year Over Year Increase in Product Revenue
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...